HARBIN, China--(BUSINESS WIRE)--China Sky One Medical, Inc. (OTCBB:CSKI), one of the leading producers and distributors for external-use Chinese medicines in China, has announced that a strategic agreement was reached early this year between China Sky One Medical, Inc. and Takasima Industries. As a result of this agreement, Takasima has been engaged as the sole agent of CSKI’s patch products in Malaysia. Takasima has commenced its efforts with CSKI’s Slim Patch product line. The Slim Patch is a weight loss product that is currently sold in China under the “Tian Di Ren” brand. The Slim Patch will be repackaged and sold in Malaysia under the “Takasima” brand name. The strategic agreement also provides that Takasima will generate sales revenue of approximately USD$1.0 million per month. Since the signing of the agreement early this year, Takasima has fulfilled its monthly obligation. Management anticipates that this strategic agreement could result in up to USD$12 million in additional annual sales revenue in 2007, with a net profit margin of approximately 20%. The agreement also provides that Takasima has a first right of refusal to become the sole distributor of the Slim Patch in all of Southeast Asia.
